Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Extracts of Crataegus oxyacantha and Rosmarinus officinalis Attenuate Ischemic Myocardial Damage by Decreasing Oxidative Stress and Regulating the Production of Cardiac Vasoactive Agents.
Cuevas-Durán RE, Medrano-Rodríguez JC, Sánchez-Aguilar M, Soria-Castro E, Rubio-Ruíz ME, Del Valle-Mondragón L, Sánchez-Mendoza A, Torres-Narvaéz JC, Pastelín-Hernández G, Ibarra-Lara L. Cuevas-Durán RE, et al. Among authors: ibarra lara l. Int J Mol Sci. 2017 Nov 14;18(11):2412. doi: 10.3390/ijms18112412. Int J Mol Sci. 2017. PMID: 29135932 Free PMC article.
Clofibrate improves myocardial ischemia-induced damage through regulation of renin-angiotensin system and favours a pro-vasodilator profile in left ventricle.
Ibarra-Lara L, Sánchez-Aguilar M, Del Valle-Mondragón L, Soria-Castro E, Cervantes-Pérez LG, Pastelín-Hernández G, Sánchez-Mendoza A. Ibarra-Lara L, et al. J Pharmacol Sci. 2020 Dec;144(4):218-228. doi: 10.1016/j.jphs.2020.09.005. Epub 2020 Sep 18. J Pharmacol Sci. 2020. PMID: 33070841 Free article.
Clofibrate PPARα activation reduces oxidative stress and improves ultrastructure and ventricular hemodynamics in no-flow myocardial ischemia.
Ibarra-Lara L, Hong E, Soria-Castro E, Torres-Narváez JC, Pérez-Severiano F, Del Valle-Mondragón L, Cervantes-Pérez LG, Ramírez-Ortega M, Pastelín-Hernández GS, Sánchez-Mendoza A. Ibarra-Lara L, et al. J Cardiovasc Pharmacol. 2012 Oct;60(4):323-34. doi: 10.1097/FJC.0b013e31826216ed. J Cardiovasc Pharmacol. 2012. PMID: 22691880
Fenofibrate Therapy Restores Antioxidant Protection and Improves Myocardial Insulin Resistance in a Rat Model of Metabolic Syndrome and Myocardial Ischemia: The Role of Angiotensin II.
Ibarra-Lara L, Sánchez-Aguilar M, Sánchez-Mendoza A, Del Valle-Mondragón L, Soria-Castro E, Carreón-Torres E, Díaz-Díaz E, Vázquez-Meza H, Guarner-Lans V, Rubio-Ruiz ME. Ibarra-Lara L, et al. Molecules. 2016 Dec 28;22(1):31. doi: 10.3390/molecules22010031. Molecules. 2016. PMID: 28036029 Free PMC article.
PPARalpha stimulation exerts a blood pressure lowering effect through different mechanisms in a time-dependent manner.
Ibarra-Lara L, Cervantes-Pérez LG, Pérez-Severiano F, Del Valle L, Rubio-Ruíz E, Soria-Castro E, Pastelín-Hernández GS, Sánchez-Aguilar M, Martínez-Lazcano JC, Sánchez-Mendoza A. Ibarra-Lara L, et al. Eur J Pharmacol. 2010 Feb 10;627(1-3):185-93. doi: 10.1016/j.ejphar.2009.10.039. Epub 2009 Oct 24. Eur J Pharmacol. 2010. PMID: 19857485
PPARα Stimulation Modulates Myocardial Ischemia-induced Activation of Renin-Angiotensin System.
Ibarra-Lara L, Sánchez-Aguilar M, Hong E, del Valle-Mondragón L, Soria-Castro E, Pérez-Severiano F, Torres-Narváez JC, Ramírez-Ortega M, Pastelín-Hernández GS, Cervantes-Pérez LG, Sánchez-Mendoza A. Ibarra-Lara L, et al. J Cardiovasc Pharmacol. 2015 May;65(5):430-7. doi: 10.1097/FJC.0000000000000186. J Cardiovasc Pharmacol. 2015. PMID: 25658458
Peroxisome proliferator-activated receptor-α stimulation by clofibrate favors an antioxidant and vasodilator environment in a stressed left ventricle.
Ibarra-Lara L, Del Valle-Mondragón L, Soria-Castro E, Torres-Narváez JC, Pérez-Severiano F, Sánchez-Aguilar M, Ramírez-Ortega M, Cervantes-Pérez LG, Pastelín-Hernández GS, Oidor-Chan VH, Zarco-Olvera G, Sánchez-Mendoza A. Ibarra-Lara L, et al. Pharmacol Rep. 2016 Aug;68(4):692-702. doi: 10.1016/j.pharep.2016.03.002. Epub 2016 Mar 21. Pharmacol Rep. 2016. PMID: 27110876
Rosiglitazone, a Ligand to PPARγ, Improves Blood Pressure and Vascular Function through Renin-Angiotensin System Regulation.
Sánchez-Aguilar M, Ibarra-Lara L, Del Valle-Mondragón L, Rubio-Ruiz ME, Aguilar-Navarro AG, Zamorano-Carrillo A, Ramírez-Ortega MDC, Pastelín-Hernández G, Sánchez-Mendoza A. Sánchez-Aguilar M, et al. Among authors: ibarra lara l. PPAR Res. 2019 Feb 3;2019:1371758. doi: 10.1155/2019/1371758. eCollection 2019. PPAR Res. 2019. PMID: 30863432 Free PMC article.
Nonclassical Axis of the Renin-Angiotensin System and Neprilysin: Key Mediators That Underlie the Cardioprotective Effect of PPAR-Alpha Activation during Myocardial Ischemia in a Metabolic Syndrome Model.
Sánchez-Aguilar M, Ibarra-Lara L, Del Valle-Mondragón L, Soria-Castro E, Torres-Narváez JC, Carreón-Torres E, Sánchez-Mendoza A, Rubio-Ruíz ME. Sánchez-Aguilar M, et al. Among authors: ibarra lara l. PPAR Res. 2020 Nov 27;2020:8894525. doi: 10.1155/2020/8894525. eCollection 2020. PPAR Res. 2020. PMID: 33354204 Free PMC article.
13 results